AIDS and Behavior provides an international venue for the scientific exchange of research and scholarly work on the contributing factors, prevention, consequences, social impact, and response to HIV/AIDS. The journal publishes original peer-reviewed papers addressing all areas of AIDS behavioral research including: individual, contextual, social, economic and geographic factors that facilitate HIV transmission; interventions aimed to reduce HIV transmission risks at all levels and in all contexts; mental health aspects of HIV/AIDS; medical and behavioral consequences of HIV infection - including health-related quality of life, coping, treatment and treatment adherence; and the impact of HIV infection on adults children, families, communities and societies. The journal publishes original research articles, brief research reports, and critical literature reviews.
Researchers at Yale and the VA Pittsburgh Healthcare System compared the number of drinks that men with HIV infection, versus those without it, needed to get a buzz. They found that HIV-infected men were more sensitive to ...
Apr 20, 2015
2
35
The United States has a proven treatment to reduce HIV infection risk by up to 99%. The health system just needs to get better at offering it. In 2021, the country had over 36,000 new HIV diagnoses, yet PrEP (HIV pre-exposure ...
Sep 26, 2023
0
19
Research has shown that drug and alcohol use interferes with anti-retroviral medication adherence among gay and bisexual men (GBM) living with HIV. There is limited parallel examination of whether the same holds true for ...
Oct 23, 2018
0
26
Across the globe, HIV prevalence among sex workers is estimated to be as much as 12 times that of the general population. In Kenya, HIV prevalence among sex workers is about 30 percent compared to 5.4 percent in the general ...
Aug 22, 2018
0
0
The Adherence Connection for Counseling, Education, and Support (ACCESS) peer-led, mobile health cognitive behavioral antiretroviral therapy (ART) adherence intervention improves adherence to ART for adolescents and young ...
Jan 9, 2023
0
2
Multiple barriers may stop high-risk individuals from accessing an HIV drug that can reduce the subsequent risk of infection, according to a new University of Michigan study.
Jun 11, 2018
0
30
A new paper out of the iPrEx study—a randomized, placebo-controlled trial of daily oral HIV pre-exposure prophylaxis (PrEP) in men and transgender women who have sex with men—reported no link between taking Truvada for ...
Jun 19, 2015
0
50
Methodological limitations in HIV drug implementation studies help to explain why high-risk individuals are not accessing pre-exposure prophylaxis (PrEP) that can reduce the subsequent risk of HIV infection, according to ...
Jul 15, 2019
0
28
The COVID-19 pandemic overwhelmed health care systems across the United States. More than 100 million cases and one million deaths later, clinicians and researchers are still unraveling the lessons learned from this global ...
Oct 28, 2023
0
0
Cisgender sexual minority men and transgender women are aware of pre-exposure prophylaxis (PrEP), a daily pill for HIV-negative people to prevent HIV infection, but few are currently taking it, according to researchers at ...
Apr 21, 2021
0
9
